title: Role of Alpha Blockers in Hypertension with Benign Prostatic Hyperplasia.
abstract: Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.
authors.forename: R P
authors.initials: RP
authors.lastname: Mathur
authors.forename: Sumanlata
authors.initials: S
authors.lastname: Nayak
authors.forename: R
authors.initials: R
authors.lastname: Sivaramakrishnan
authors.forename: Vikas
authors.initials: V
authors.lastname: Jain
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001341:Autonomic Nervous System / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology
chemical_list: D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents